Last reviewed · How we verify

NCT03992274: B-HAPPY

Biomedical HIV/AIDS Prevention Program Yunnan

Terminated NA Results posted Last updated 30 January 2025
What this trial tests

NA trial testing Enhanced implementation of PrEP in HIV/AIDS in 114 participants. Terminated before completion.

Timeline
1 August 2020
Primary endpoint
27 September 2023
27 September 2023

Quick facts

Lead sponsorColumbia University
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment114
Start date1 August 2020
Primary completion27 September 2023
Estimated completion27 September 2023
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Columbia University

Who can join

18 and older, male only, with HIV/AIDS. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

B-HAPPY is an implementation project to study the process by which pre-exposure prophylaxis (PrEP) is introduced and integrated into a specific international health system facing high rates of HIV incidence among men who have sex with men. The study will use a stepped wedge design to compare implementation outcomes across eight municipalities in Yunnan, China.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for HIV/AIDS

Currently open trials in the same condition.

Other Columbia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03992274.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing